Standard Biotools Inc. · NASDAQ:LAB
Egholm Michael received 1,042,373 Standard Biotools Inc. shares as an award (Form 4)
Traded Mar 20 to Apr 6, 2026 · Filed Apr 8, 2026
From Mar 20 to Apr 6, 2026, Egholm Michael (Director, President & CEO) received 1,042,373 Standard Biotools Inc. shares as an award, leaving 6,695,582 shares. Filed Apr 8, 2026 (Form 4).
- Awarded
- 1,042,373 shares
- Holding after
- 6,695,582 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Common Stock | Award | 1,042,373 | 6,594,083 | Direct | |
| Apr 6, 2026 | Common Stock | Option exercise | 196,513 | 6,790,596 | Direct | |
| Apr 6, 2026 | Common Stock | Shares withheld for tax | 95,014 | US$0.91 | 6,695,582 | Direct |
Source
Related
- Standard Biotools Inc.
- Egholm Michael
- Standard Biotools Inc. shareholders
- Form 4 · Egholm Michael · Aug 24, 2026
- Form 4 · Egholm Michael · Aug 4, 2026
- Form 4 · Egholm Michael · May 22, 2026
- Form 4 · Mackay Sean · Aug 24, 2026
- Form 4 · Kim Hanjoon Alex · Aug 24, 2026
- Schedule 13G · Long Focus Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Mak Capital One LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 30, 2026